ClinConnect ClinConnect Logo
Search / Trial NCT04682470

The Prospective Observational COMPRAYA Cohort Study

Launched by THE NETHERLANDS CANCER INSTITUTE · Dec 22, 2020

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

The COMPRAYA study is a research project focused on understanding the health and emotional challenges faced by young adults aged 18 to 39 who have been diagnosed with cancer. Researchers want to learn more about the various factors that can affect their well-being after treatment, including medical issues like second cancers or fertility problems, as well as emotional challenges such as stress. By gathering information from these young cancer survivors, the study aims to improve future cancer care and support for patients in this age group.

To be eligible for the study, participants must be between 18 and 39 years old and have a confirmed cancer diagnosis. They will be asked to fill out questionnaires each year for at least 10 years and provide samples of blood, hair, and stool at three points in time: shortly after diagnosis, and then again after two and five years. While participants may not see direct benefits from their involvement, their contributions will help researchers gain valuable insights that can lead to better care for future young cancer patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Pathological confirmed cancer diagnosis;
  • Age 18 - 39 years at time of first cancer diagnosis;
  • Able to understand the informed consent form;
  • Provide written informed consent.
  • Exclusion Criteria:
  • Mentally incompetent patients based on the opinion of treating physician .
  • Inability to understand the Dutch language
  • Life expectancy less than 6 months based on the opinion of treating physician .

About The Netherlands Cancer Institute

The Netherlands Cancer Institute (NKI) is a leading research and treatment center dedicated to advancing the understanding and management of cancer. Renowned for its cutting-edge research, NKI fosters innovation in oncology through a multidisciplinary approach that integrates laboratory research, clinical trials, and patient care. With a commitment to translating scientific discoveries into effective therapies, the institute collaborates with national and international partners to enhance cancer treatment outcomes. NKI's state-of-the-art facilities and expertise in various cancer types position it as a pivotal contributor to the global fight against cancer, aiming to improve survival rates and quality of life for patients.

Locations

Amsterdam, Noord Holland, Netherlands

Patients applied

0 patients applied

Trial Officials

Olga Husson, Phd

Principal Investigator

Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital (NKI-AvL)

Winette van de Graaf, Prof

Study Director

Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AvL)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials